SEC Form 4 · accession 0002123843-26-000005
Rani Therapeutics Holdings, Inc. · RANI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alireza Javadi
Officer — Chief Technical Officer
Period of report
Jun 3, 2026
Accepted (ET)
Jun 5, 2026 · 6:17 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001856725
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $0.875 | Jun 3, 2026 | A | 805,500 | A | — | Jun 2, 2036 | Class A Common Stock | 805,500 | 805,500 | D |
Explanation of responses
- F1The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from April 1, 2026, subject to the Reporting Person's Continuous Service (as defined in the Company's 2021 Equity Incentive Plan) through each such vesting date.